GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to the British drugmaker’s pipeline of potential treatments for lupus.

GSK (GSK) plc and Chimagen Biosciences, a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager, from ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £15.50. The company’s shares opened today ...

This article will explore 15 of the most iconic logos ever created. We'll examine what makes them memorable, their history, and their impact. Logos are an essential part of any brand's identity. An ...

Let's plug into the power of great branding design and explore ten electronics logos that have wired themselves into our collective consciousness. In a world drowning in noise, the whisper of a great ...

For instance, many wonder if they can change the boot logo in Windows 10. By default, every time you boot the OS, a Windows logo appears on the screen with a few dots spinning in a circle which ...

We may get a commission if you buy through our links. Windows 11 isn’t known for its customization features, but many are wondering how to change boot logo in Windows 11, and in this guide, we’re ...

Together with GSK, the Boston-based research team will focus on understanding how dysfunctional lung epithelial cells initiate and perpetuate the disease, including alveolar type 2 (AT2) cells ...

The premium label is debuting a Blanc de Noirs Vintage 2015 that will ... catching metallic bottles with the raised ace of spades logo prominently displayed, normally sell from upwards of $300.

The update on the GSK-partnered prospect sent Wave’s share price up 63% to almost $14 despite coinciding with news that Takeda has axed a deal for another asset. The ongoing phase 1b/2a study is ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...

GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...